Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KJEKSHUS, John")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 56

  • Page / 3
Export

Selection :

  • and

Is there a heart rate paradox - demystification of the myths?KJEKSHUS, John.Journal of internal medicine. 2009, Vol 266, Num 3, pp 242-247, issn 0954-6820, 6 p.Article

Comparison of baseline data, initial course, and management : Losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial)DICKSTEIN, Kenneth; KJEKSHUS, John.The American journal of cardiology. 2001, Vol 87, Num 6, pp 766-771, issn 0002-9149Article

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trialDICKSTEIN, Kenneth; KJEKSHUS, John.Lancet (British edition). 2002, Vol 360, Num 9335, pp 752-760, issn 0140-6736Article

Mechanisms behind the postprandial increase in cardiac output : a clue obtained from transplanted heartsWAALER, Bjarne A; HISDAL, Jonny; IHLEN, Halfdan et al.European journal of applied physiology. 2006, Vol 97, Num 5, pp 516-520, 5 p.Article

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocordial infarction associated with heart failureHOGNESTAD, Aina; DICKSTEIN, Kenneth; MYHRE, Eivind et al.The American journal of cardiology. 2004, Vol 93, Num 5, pp 603-606, issn 0002-9149, 4 p.Article

N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac diseaseHALL, Christian; IHLEN, Halfdan; BONARJEE, Vernon et al.International journal of cardiology. 2003, Vol 89, Num 2-3, pp 197-205, issn 0167-5273, 9 p.Article

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) : Genetic and protein markers of CVDGULLESTAD, Lars; UELAND, Thor; CLELAND, John G. F et al.European heart journal. 2012, Vol 33, Num 18, pp 2290-2296, issn 0195-668X, 7 p.Article

Increased systemic and myocardial expression of neutrophit getatinase-associated tipocatin in clinical and experimental heart failureYNDESTAD, Arne; LANDRØ, Linn; DICKSTEIN, Kenneth et al.European heart journal. 2009, Vol 30, Num 10, pp 1229-1236, issn 0195-668X, 8 p.Article

Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin: A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)CLELAND, John G. F; MCMURRAY, John J. V; VAN VELDHUISEN, Dirk J et al.Journal of the American College of Cardiology. 2009, Vol 54, Num 20, pp 1850-1859, issn 0735-1097, 10 p.Article

Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodelingGURANTZ, Devorah; YNDESTAD, Arne; HALVORSEN, Bente et al.Cardiovascular research. 2005, Vol 67, Num 1, pp 106-115, issn 0008-6363, 10 p.Article

Challenges of subgroup analyses in multinational clinical trials : Experiences from the MERIT-HF trialWEDEL, Hans; DEMETS, David; DEEDWANIA, Prakash et al.The American heart journal. 2001, Vol 142, Num 3, pp 502-511, issn 0002-8703Article

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)CATAPANO, Alberico L; REINER, Zeljko; ERDINE, Serap et al.Atherosclerosis. 2011, Vol 217, Num 1, pp 3-46, issn 0021-9150, 44 p.Article

Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trialANKER, Stefan D; VOORS, Adriaan; OKONKO, Darlington et al.European heart journal. 2009, Vol 30, Num 11, pp 1331-1339, issn 0195-668X, 9 p.Article

Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide- derived end products in hyperhomocysteinemic subjectsHOLVEN, Kirsten B; HOLM, Torbjørn; NENSETER, Marit S et al.The American journal of medicine. 2001, Vol 110, Num 7, pp 536-542, issn 0002-9343Article

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to Simvastatin therapy in 4SBALLANTYNE, Christie M; OLSSON, Anders G; COOK, Thomas J et al.Circulation (New York, N.Y.). 2001, Vol 104, Num 25, pp 3046-3051, issn 0009-7322Article

Metoprolol controlled release/extended release in patients with severe Heart Failure: Analysis of the experience in the MERIT-HF studyGOLDSTEIN, Sidney; FAGERBERG, Björn; HJALMARSON, Ake et al.Journal of the American College of Cardiology. 2001, Vol 38, Num 4, pp 932-938, issn 0735-1097Article

Omega-3 fatty acids enhance tumor necrosis factor-a levels in heart transplant recipientsHOLM, Torbjørn; BERGE, Rolf K; ANDREASSEN, Arne K et al.Transplantation. 2001, Vol 72, Num 4, pp 706-711, issn 0041-1337Article

Effect of Pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipientsHOLM, Torbjørr; ANDREASSEN, Arne K; UELAND, Thor et al.The American journal of cardiology. 2001, Vol 87, Num 6, pp 815-818, issn 0002-9149Article

Peripheral artery disease and outcomes after myocardial infarction: An individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANTINGLIS, Sally C; BEBCHUK, Judith; KJEKSHUS, John et al.International journal of cardiology. 2013, Vol 168, Num 2, pp 1094-1101, issn 0167-5273, 8 p.Article

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)GULLESTAD, Lars; UELAND, Thor; KJEKSHUS, John et al.The American heart journal. 2012, Vol 164, Num 6, pp 878-883, issn 0002-8703, 6 p.Article

Effect of simvastatin on kidney function loss in patients with coronary heart disease Findings from the Scandinavian Simvastatin Survival Study (4S)HUSKEY, Janna; LINDENFELD, Joann; COOK, Thomas et al.Atherosclerosis. 2009, Vol 205, Num 1, pp 202-206, issn 0021-9150, 5 p.Article

Impact of neurohormonal blockade on association between body mass index and mortalityKENNEDY, Linn M. A; ANKER, Stefan D; KJEKSHUS, John et al.International journal of cardiology. 2007, Vol 119, Num 1, pp 33-40, issn 0167-5273, 8 p.Article

Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patientsUELAND, Thor; KJEKSHUS, John; FRØLAND, Stig S et al.Journal of the American College of Cardiology. 2005, Vol 46, Num 11, pp 2018-2021, issn 0735-1097, 4 p.Article

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (45) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)GIRMAN, Cynthia J; RHODES, Thomas; MERCURI, Michele et al.The American journal of cardiology. 2004, Vol 93, Num 2, pp 136-141, issn 0002-9149, 6 p.Article

Stenting In small coronary arteries (SISCA) trial: A randomized comparison between balloon angioplasty and the heparin-coated beStent. CommentaryMOER, Rasmus; MYRENG, Yngvar; KASTRATI, Adnan et al.Journal of the American College of Cardiology. 2001, Vol 38, Num 6, pp 1598-1607, issn 0735-1097Article

  • Page / 3